Re: Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer

European Urology

Volumn 63, Issue 1, 2013, Pages 181-182

  Efstathiou, Jason A ^a   Shipley, William U ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; MITOMYCIN C; RADIOSENSITIZING AGENT;

ADJUVANT CHEMORADIOTHERAPY; BLADDER CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMORADIOTHERAPY; CLINICAL EVALUATION; CYSTECTOMY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; GASTROINTESTINAL TOXICITY; HAZARD RATIO; HUMAN; METASTASIS FREE SURVIVAL; MUSCLE INVASIVE BLADDER CANCER; NOTE; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIOSENSITIZATION; RISK REDUCTION; UROGENITAL TRACT TOXICITY;

EID: 84870545811     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.10.032     Document Type: Note

References (5)

1. W.U. Shipley, G.R. Prout Jr., and A.B. Einstein Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery JAMA 258 1987 931 935
2. J.A. Efstathiou, D.Y. Spiegel, and W.U. Shipley Long-term outcomes of selective bladder preservation by combined-modality therapy for invasive bladder cancer: the MGH experience Eur Urol 61 2012 705 711
3. P. Zehnder, U.E. Studer, and E.C. Skinner Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study J Urol 186 2011 1261 1268
4. J.A. Ajani, K.A. Winter, and L.L. Gunderson Combined therapy for cancer of the anal canal: a preliminary report JAMA 299 2008 1914 1921
5. G. Gakis, J. Efstathiou, and S.P. Lerner ICUD-EAU International Consultation on Bladder Cancer 2012: radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder Eur Urol 63 2013 45 57